Exposure of hydrophobic surfaces initiates aggregation of diverse ALS-causing superoxide dismutase-1 mutants

Journal of Molecular Biology

Volumn 399, Issue 3, 2010, Pages 512-525

  Münch, Christian ^a   Bertolotti, Anne ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Aggregation; Amyotrophic lateral sclerosis; Neurodegeneration; Superoxide dismutase

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE;

AMINO ACID SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; FLUORESCENCE ANALYSIS; HUMAN; HYDROPHOBICITY; MISSENSE MUTATION; MOLECULAR MECHANICS; MUTANT; PRIORITY JOURNAL; PROTEIN AGGREGATION;

EID: 77954757268     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2010.04.019     Document Type: Article

References (54)

1. Bruijn L.I., Miller T.M., Cleveland D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 2004, 27:723-749.
2. Valentine J.S., Doucette P.A., Zittin Potter S. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu. Rev. Biochem. 2005, 74:563-593.
3. Reaume A.G., Elliott J.L., Hoffman E.K., Kowall N.W., Ferrante R.J., Siwek D.F., et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet. 1996, 13:43-47.
4. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 1994, 264:1772-1775.
5. Shibata N., Hirano A., Kobayashi M., Siddique T., Deng H.X., Hung W.Y., et al. Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J. Neuropathol. Exp. Neurol. 1996, 55:481-490.
6. Kato S., Nakashima K., Horiuchi S., Nagai R., Cleveland D.W., Liu J., et al. Formation of advanced glycation end-product-modified superoxide dismutase-1 (SOD1) is one of the mechanisms responsible for inclusions common to familial amyotrophic lateral sclerosis patients with SOD1 gene mutation, and transgenic mice expressing human SOD1 gene mutation. Neuropathology 2001, 21:67-81.
7. Bruijn L.I., Houseweart M.K., Kato S., Anderson K.L., Anderson S.D., Ohama E., et al. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 1998, 281:1851-1854.
8. Lindberg M.J., Tibell L., Oliveberg M. Common denominator of Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis: decreased stability of the apo state. Proc. Natl Acad. Sci. USA 2002, 99:16607-16612.
9. Hayward L.J., Rodriguez J.A., Kim J.W., Tiwari A., Goto J.J., Cabelli D.E., et al. Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis. J. Biol. Chem. 2002, 277:15923-15931.
10. Rodriguez J.A., Shaw B.F., Durazo A., Sohn S.H., Doucette P.A., Nersissian A.M., et al. Destabilization of apoprotein is insufficient to explain Cu,Zn-superoxide dismutase-linked ALS pathogenesis. Proc. Natl Acad. Sci. USA 2005, 102:10516-10521.
11. Banci L., Bertini I., Durazo A., Girotto S., Gralla E.B., Martinelli M., et al. Metal-free superoxide dismutase forms soluble oligomers under physiological conditions: a possible general mechanism for familial ALS. Proc. Natl Acad. Sci. USA 2007, 104:11263-11267.
12. Durazo A., Shaw B.F., Chattopadhyay M., Faull K.F., Nersissian A.M., Valentine J.S., Whitelegge J.P. Metal-free superoxide dismutase-1 and three different amyotrophic lateral sclerosis variants share a similar partially unfolded beta-barrel at physiological temperature. J. Biol. Chem. 2009, 284:34382-34389.
13. Tiwari A., Hayward L.J. Familial amyotrophic lateral sclerosis mutants of copper/zinc superoxide dismutase are susceptible to disulfide reduction. J. Biol. Chem. 2003, 278:5984-5992.
14. Lindberg M.J., Normark J., Holmgren A., Oliveberg M. Folding of human superoxide dismutase: disulfide reduction prevents dimerization and produces marginally stable monomers. Proc. Natl Acad. Sci. USA 2004, 101:15893-15898.
15. Chattopadhyay M., Durazo A., Sohn S.H., Strong C.D., Gralla E.B., Whitelegge J.P., Valentine J.S. Initiation and elongation in fibrillation of ALS-linked superoxide dismutase. Proc. Natl Acad. Sci. USA 2008, 105:18663-18668.
16. Karch C.M., Prudencio M., Winkler D.D., Hart P.J., Borchelt D.R. Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS. Proc. Natl Acad. Sci. USA 2009, 106:7774-7779.
17. Rakhit R., Cunningham P., Furtos-Matei A., Dahan S., Qi X.F., Crow J.P., et al. Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. J. Biol. Chem. 2002, 277:47551-47556.
18. Hough M.A., Grossmann J.G., Antonyuk S.V., Strange R.W., Doucette P.A., Rodriguez J.A., et al. Dimer destabilization in superoxide dismutase may result in disease-causing properties: structures of motor neuron disease mutants. Proc. Natl Acad. Sci. USA 2004, 101:5976-5981.
19. Wang J., Caruano-Yzermans A., Rodriguez A., Scheurmann J.P., Slunt H.H., Cao X., et al. Disease-associated mutations at copper ligand histidine residues of superoxide dismutase 1 diminish the binding of copper and compromise dimer stability. J. Biol. Chem. 2007, 282:345-352.
20. Furukawa Y., Kaneko K., Yamanaka K., O'Halloran T.V., Nukina N. Complete loss of post-translational modifications triggers fibrillar aggregation of SOD1 in the familial form of amyotrophic lateral sclerosis. J. Biol. Chem. 2008, 283:24167-24176.
21. Wilcox K.C., Zhou L., Jordon J.K., Huang Y., Yu Y., Redler R.L., et al. Modifications of superoxide dismutase (SOD1) in human erythrocytes: a possible role in amyotrophic lateral sclerosis. J. Biol. Chem. 2009, 284:13940-13947.
22. Sandelin E., Nordlund A., Andersen P.M., Marklund S.S., Oliveberg M. Amyotrophic lateral sclerosis-associated copper/zinc superoxide dismutase mutations preferentially reduce the repulsive charge of the proteins. J. Biol. Chem. 2007, 282:21230-21236.
23. Tiwari A., Xu Z., Hayward L.J. Aberrantly increased hydrophobicity shared by mutants of Cu,Zn-superoxide dismutase in familial amyotrophic lateral sclerosis. J. Biol. Chem. 2005, 280:29771-29779.
24. Lindberg M.J., Bystrom R., Boknas N., Andersen P.M., Oliveberg M. Systematically perturbed folding patterns of amyotrophic lateral sclerosis (ALS)-associated SOD1 mutants. Proc. Natl Acad. Sci. USA 2005, 102:9754-9759.
25. Bruns C.K., Kopito R.R. Impaired post-translational folding of familial ALS-linked Cu, Zn superoxide dismutase mutants. EMBO J. 2007, 26:855-866.
26. Rumfeldt J.A., Lepock J.R., Meiering E.M. Unfolding and folding kinetics of amyotrophic lateral sclerosis-associated mutant Cu,Zn superoxide dismutases. J. Mol. Biol. 2009, 385:278-298.
27. Hawe A., Sutter M., Jiskoot W. Extrinsic fluorescent dyes as tools for protein characterization. Pharm. Res. 2008, 25:1487-1499.
28. Nordlund A., Oliveberg M. SOD1-associated ALS: a promising system for elucidating the origin of protein-misfolding disease. HFSP J. 2008, 2:354-364.
29. Wang Q., Johnson J.L., Agar N.Y., Agar J.N. Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival. PLoS Biol. 2008, 6:e170.
30. Ratovitski T., Corson L.B., Strain J., Wong P., Cleveland D.W., Culotta V.C., Borchelt D.R. Variation in the biochemical/biophysical properties of mutant superoxide dismutase 1 enzymes and the rate of disease progression in familial amyotrophic lateral sclerosis kindreds. Hum. Mol. Genet. 1999, 8:1451-1460.
31. Ohi T., Nabeshima K., Kato S., Yazawa S., Takechi S. Familial amyotrophic lateral sclerosis with His46Arg mutation in Cu/Zn superoxide dismutase presenting characteristic clinical features and Lewy body-like hyaline inclusions. J. Neurol. Sci. 2004, 225:19-25.
32. Tiwari A., Liba A., Sohn S.H., Seetharaman S.V., Bilsel O., Matthews C.R., et al. Metal deficiency increases aberrant hydrophobicity of mutant superoxide dismutases that cause amyotrophic lateral sclerosis. J. Biol. Chem. 2009, 58:2565-2573.
33. Stathopulos P.B., Rumfeldt J.A., Scholz G.A., Irani R.A., Frey H.E., Hallewell R.A., et al. Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis show enhanced formation of aggregates in vitro. Proc. Natl Acad. Sci. USA 2003, 100:7021-7026.
34. Lo M.C., Aulabaugh A., Jin G., Cowling R., Bard J., Malamas M., Ellestad G. Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery. Anal. Biochem. 2004, 332:153-159.
35. DiDonato M., Craig L., Huff M.E., Thayer M.M., Cardoso R.M., Kassmann C.J., et al. ALS mutants of human superoxide dismutase form fibrous aggregates via framework destabilization. J. Mol. Biol. 2003, 332:601-615.
36. Arnesano F., Banci L., Bertini I., Martinelli M., Furukawa Y., O'Halloran T.V. The unusually stable quaternary structure of human Cu,Zn-superoxide dismutase 1 is controlled by both metal occupancy and disulfide status. J. Biol. Chem. 2004, 279:47998-48003.
37. Khare S.D., Caplow M., Dokholyan N.V. The rate and equilibrium constants for a multistep reaction sequence for the aggregation of superoxide dismutase in amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 2004, 101:15094-15099.
38. Chiti F., Webster P., Taddei N., Clark A., Stefani M., Ramponi G., Dobson C.M. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl Acad. Sci. USA 1999, 96:3590-3594.
39. Wang J., Xu G., Gonzales V., Coonfield M., Fromholt D., Copeland N.G., et al. Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site. Neurobiol. Dis. 2002, 10:128-138.
40. Rousseau E., Dehay B., Ben-Haiem L., Trottier Y., Morange M., Bertolotti A. Targeting expression of expanded polyglutamine proteins to the endoplasmic reticulum or mitochondria prevents their aggregation. Proc. Natl Acad. Sci. USA 2004, 101:9648-9653.
41. Kato S., Hayashi H., Nakashima K., Nanba E., Kato M., Hirano A., et al. Pathological characterization of astrocytic hyaline inclusions in familial amyotrophic lateral sclerosis. Am. J. Pathol. 1997, 151:611-620.
42. Chiti F., Stefani M., Taddei N., Ramponi G., Dobson C.M. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 2003, 424:805-808.
43. Zibaee S., Jakes R., Fraser G., Serpell L.C., Crowther R.A., Goedert M. Sequence determinants for amyloid fibrillogenesis of human alpha-synuclein. J. Mol. Biol. 2007, 374:454-464.
44. Khare S.D., Wilcox K.C., Gong P., Dokholyan N.V. Sequence and structural determinants of Cu, Zn superoxide dismutase aggregation. Proteins 2005, 61:617-632.
45. Elam J.S., Taylor A.B., Strange R., Antonyuk S., Doucette P.A., Rodriguez J.A., et al. Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS. Nat. Struct. Biol. 2003, 10:461-467.
46. Zetterstrom P., Stewart H.G., Bergemalm D., Jonsson P.A., Graffmo K.S., Andersen P.M., et al. Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models. Proc. Natl Acad. Sci. USA 2007, 104:14157-14162.
47. Vande Velde C., Miller T.M., Cashman N.R., Cleveland D.W. Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria. Proc. Natl Acad. Sci. USA 2008, 105:4022-4027.
48. Wang J., Farr G.W., Zeiss C.J., Rodriguez-Gil D.J., Wilson J.H., Furtak K., et al. Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS. Proc. Natl Acad. Sci. USA 2009, 106:1392-1397.
49. Borchelt D.R., Guarnieri M., Wong P.C., Lee M.K., Slunt H.S., Xu Z.S., et al. Superoxide dismutase 1 subunits with mutations linked to familial amyotrophic lateral sclerosis do not affect wild-type subunit function. J. Biol. Chem. 1995, 270:3234-3238.
50. Arndt V., Rogon C., Hohfeld J. To be, or not to be-molecular chaperones in protein degradation. Cell Mol. Life Sci. 2007, 64:2525-2541.
51. Jonsson P.A., Ernhill K., Andersen P.M., Bergemalm D., Brannstrom T., Gredal O., et al. Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis. Brain 2004, 127:73-88.
52. Rousseau E., Kojima R., Hoffner G., Djian P., Bertolotti A. Misfolding of proteins with a polyglutamine expansion is facilitated by proteasomal chaperones. J. Biol. Chem. 2009, 284:1917-1929.
53. Deng H.X., Hentati A., Tainer J.A., Iqbal Z., Cayabyab A., Hung W.Y., et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 1993, 261:1047-1051.
54. Roseman M.A. Hydrophobicity of the peptide C = O.H-N hydrogen-bonded group. J. Mol. Biol. 1988, 201:621-623.